Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02092 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His)
HECL,CLL-1,CD303,PRO34150,DCAL-2,CLL1,DLEC... |
Human | HEK293 Cells |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 41~45 kDa and the accession number is EAW96132.1. | |||
TMPK-01004 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, hFc)
DCAL2,HECL,DCAL-2,DLEC,CLECSF11,CLEC12A,CD371,MICL,CLL-1,CLE... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, hF... | |||
TMPK-01003 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His, Avi), Biotinylated
DCAL2,CD371,CLEC12A,CLL-1,MICL,CD303,HECL,PRO34... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His, Avi), Bi... | |||
TMPK-01002 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc & Avi), Biotinylated
HECL,DCAL-2,CD303,CLECSF7,DCAL2,CLECSF11,CLL1,CLL-1,CD371,MI... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc & Avi), B... | |||
TMPK-01006 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, His)
CLECSF7,CLL-1,PRO34150,CLL1,DLEC,CLEC12A,D... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, Hi... | |||
TMPK-00995 |
CLEC12A/MICL/CLL-1 Protein, Mouse, Recombinant (aa 65-267, His)
HECL,CLL1,CD371,CLL-1,CLEC12A,MICL,DCAL-2,PRO34... |
Mouse | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Mouse, Recombinant (aa 65-267, Hi... | |||
TMPK-00548 |
CLEC12A/MICL/CLL-1 Protein, Cynomolgus, Recombinant (His)
CD371,HECL,CLECSF11,CLEC12A,CD303,CLL-1,PRO3415... |
Cynomolgus | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Cynomolgus, Recombinant (His) is ... | |||
TMPK-01005 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled
DCAL-2,HECL,CLL-1,CLECSF7,CD371,CLEC12A,PRO3415... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-La... | |||
TMPY-06866 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc)
CLECSF11,MICL,CLECSF7,DLEC,C-type lectin domain family 12, m... |
Human | HEK293 Cells |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 50.38 kDa and the accession number is EAW96132.1. | |||
TMPY-06881 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (Avi & Fc), Biotinylated
MICL,PRO34150,CLL1,DCAL-2,CD303,CLL-1,CD37... |
Human | HEK293 Cells |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (Avi & Fc), Biotinylated is expressed in HEK293 mammalian cells with AVI and Fc tag. The predicted molecular weight is 51.61 kDa and the accession number is EAW96132.1. |